Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2007 | 1 |
2008 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
A multicentre, open study to assess the effect of individualizing starting doses of atorvastatin according to baseline LDL-C levels on achieving cholesterol targets: the Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration (ACTFAST-2) study.
Curr Med Res Opin. 2007 Aug;23(8):1945-56. doi: 10.1185/030079907X223242.
Curr Med Res Opin. 2007.
PMID: 17626713
OBJECTIVES: ACTFAST-2 was designed to match the starting dose of a statin to the baseline low density lipoprotein-cholesterol (LDL-C) value, to allow high-risk European subjects to achieve LDL-C targets within 12 weeks with the initial dose or one up-titration. ...The tota …
OBJECTIVES: ACTFAST-2 was designed to match the starting dose of a statin to the baseline low density lipoprotein-cholesterol (LDL-C) …
How to reach LDL targets quickly in patients with diabetes or metabolic syndrome.
Leiter LA, Martineau P, de Teresa E, Farsang C, Gaw A, Gensini G, Langer A; ACTFAST 1 & 2 investigators.
Leiter LA, et al.
J Fam Pract. 2008 Oct;57(10):661-8.
J Fam Pract. 2008.
PMID: 18842192
Clinical Trial.
Among ST subjects, we observed reductions in LDL-C with atorvastatin beyond those achieved with other statins used at baseline in patients with diabetes and patients with metabolic syndrome. Atorvastatin was well tolerated. CONCLUSIONS: The ACTFAST studies confirm that a t …
Among ST subjects, we observed reductions in LDL-C with atorvastatin beyond those achieved with other statins used at baseline in patients w …
Item in Clipboard
Cite
Cite